Curcumin decreases renal triglyceride accumulation through AMPK-SREBP signaling pathway in streptozotocin-induced type 1 diabetic rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 5, 2013, Pages 796-802

  Soetikno, Vivian ^a,b   Sari, Flori R ^a   Sukumaran, Vijayakumar ^a   Lakshmanan, Arun Prasath ^a   Harima, Meilei ^a   Suzuki, Kenji ^c   Kawachi, Hiroshi ^c   Watanabe, Kenichi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b UNIVERSITY OF INDONESIA   (Indonesia)

^c NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

AMPK; Curcumin; Diabetic nephropathy; Dyslipidemia; SREBP; Streptozotocin induced diabetes

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CURCUMIN; FATTY ACID SYNTHASE; FIBRONECTIN; GELATINASE A; STEROL REGULATORY ELEMENT BINDING PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; MALE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL;

ACETYL-COA CARBOXYLASE; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CURCUMIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX PROTEINS; FATTY ACID SYNTHASES; KIDNEY; MALE; MEMBRANE PROTEINS; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TRIGLYCERIDES; VASCULAR ENDOTHELIAL GROWTH FACTORS;

RATTUS;

EID: 84876807178     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2012.04.013     Document Type: Article

References (53)

1. Catania J.M., Chen G., Parrish A.R. Role of matrix metalloproteinases in renal pathophysiologies. Am J Physiol Renal Physiol 2007, 292:F905-F911.
2. Kimmelstiel P., Wilson C. Intercapillary lesions in the glomeruli of the kidney. Am J Pathol 1936, 12:83-98.
3. Keane W.F. The role of lipids in renal disease: future challenges. Kidney Int Suppl 2000, 75:S27-S31.
4. Oda H., Keane W.F. Lipids in progression of renal disease. Kidney Int Suppl 1997, 62:S36-S38.
5. Sun L., Halaihel N., Zhang W., et al. Role of sterol regulatory element-binding protein 1 in regulation of renal lipid metabolism and glomerulosclerosis in diabetes mellitus. J Biol Chem 2002, 277:18919-18927.
6. Wang Z., Jiang T., Li J., et al. Regulation of renal lipid metabolism, lipid accumulation, and glomerulosclerosis in FVBdb/db mice with type 2 diabetes. Diabetes 2005, 54:2328-2335.
7. Brown M.S., Goldstein J.L. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997, 89:331-340.
8. Horton J.D., Shimomura I. Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis. Curr Opin Lipidol 1999, 10:143-150.
9. Rawson R.B. Control of lipid metabolism by regulated intramembrane proteolysis of sterol regulatory element binding proteins (SREBPs). Biochem Soc Symp 2003, 70:221-231.
10. Proctor G., Jiang T., Iwahashi M., et al. Regulation of renal fatty acid and cholesterol metabolism, inflammation, and fibrosis in Akita and OVE26 mice with type 1 diabetes. Diabetes 2006, 55:2502-2509.
11. Ishigaki N., Yamamoto T., Shimizu Y., et al. Involvement of glomerular SREBP-1c in diabetic nephropathy. Biochem Biophys Res Commun 2007, 364:502-508.
12. Hardie D.G. AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 2007, 47:185-210.
13. Zhou G., Myers R., Li Y., et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 2001, 108:1167-1174.
14. Yang J., Craddock L., Hong S., et al. AMP-activated protein kinase suppresses LXR-dependent sterol regulatory element-binding protein-1c transcription in rat hepatoma McA-RH7777 cells. J Cell Biochem 2009, 106:414-426.
15. Goel A., Kunnumakkara A.B., Aggarwal B.B. Curcumin as "Curecumin": from kitchen to clinic. Biochem Pharmacol 2008, 75:787-809.
16. Babu P.S., Srinivasan K. Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 1997, 166:169-175.
17. Peschel D., Koerting R., Nass N. Curcumin induces changes in expression of genes involved in cholesterol homeostasis. J Nutr Biochem 2007, 18:113-119.
18. Yuan H.Y., Kuang S.Y., Zheng X., et al. Curcumin inhibits cellular cholesterol accumulation by regulating SREBP-1/caveolin-1signaling pathway in vascular smooth muscle cells. Acta Pharmacol Sin 2008, 29:555-563.
19. Fan C., Wo X., Dou X., et al. Regulation of LDL receptor expression by the effect of curcumin on sterol regulatory element pathway. Pharmacol Rep 2006, 58:577-581.
20. Dou X., Fan C., Wo L., et al. Curcumin up-regulates LDL receptor expression via the sterol regulatory element pathway in HepG2 cells. Planta Med 2008, 74:1374-1379.
21. Kim T., Davis J., Zhang A.J., et al. Curcumin activates AMPK and suppresses gluconeogenic gene expression in hepatoma cells. Biochem Biophys Res Commun 2009, 388:377-382.
22. Kowluru R.A., Kanwar M. Effects of curcumin on retinal oxidative stress and inflammation in diabetes. Nutr Metab (Lond) 2007, 4:8.
23. Meghana K., Sanjeev G., Ramesh B. Curcumin prevents streptozotocin-induced islet damage by scavenging free radicals: a prophylactic and protective role. Eur J Pharmacol 2007, 577:183-191.
24. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
25. Husdan H., Rapoport A. Estimation of creatinine by the Jaffe reaction. A comparison of three methods. Clin Chem 1968, 14:222-238.
26. Bagheri F., Gol A., Dabiri S., et al. Preventive effect of garlic juice on renal reperfusion injury. Iran J Kidney Dis 2011, 5:194-200.
27. Bligh E.G., Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959, 37:911-917.
28. Thallas-Bonke V., Thorpe S.R., Coughlan M.T., et al. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008, 57:460-469.
29. Ghosh S.S., Massey H.D., Krieg R., et al. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation. Am J Physiol Renal Physiol 2009, 296:F1146-F1157.
30. Jiang T., Wang Z., Proctor G., et al. Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway. J Biol Chem 2005, 280:32317-32325.
31. Gao J., Serrero G. Adipose differentiation related protein (ADRP) expressed in transfected COS-7 cells selectively stimulates long chain fatty acid uptake. J Biol Chem 1999, 274:16825-16830.
32. Xia Z., Kuo K.H., Nagareddy P.R., et al. N-acetylcysteine attenuates PKCbeta2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc Res 2007, 73:770-782.
33. McManaman J.L., Palmer C.A., Wright R.M., et al. Functional regulation of xanthine oxidoreductase expression and localization in the mouse mammary gland: evidence of a role in lipid secretion. J Physiol 2002, 545:567-579.
34. Shimano H. Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res 2001, 40:439-452.
35. DeBose-Boyd R.A., Ou J., Goldstein J.L., et al. Expression of sterol regulatory element-binding protein 1c (SREBP-1c) mRNA in rat hepatoma cells requires endogenous LXR ligands. Proc Natl Acad Sci U S A 2001, 98:1477-1482.
36. Basile D.P. The transforming growth factor beta system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999, 8:21-30.
37. de Vriese A.S., Tilton R.G., Elger M., et al. Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes. J Am Soc Nephrol 2001, 12:993-1000.
38. Soetikno V., Sari F.R., Veeraveedu P.T., et al. Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin induced-diabetic nephropathy. Nutr Metab (Lond) 2011, 8:35.
39. Na L.X., Zhang Y.L., Li Y., et al. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr Metab Cardiovasc Dis 2011, 21:526-533.
40. Kanitkar M., Gokhale K., Galande S., et al. Novel role of curcumin in the prevention of cytokine-induced islet death in vitro and diabetogenesis in vivo. Br J Pharmacol 2008, 155:702-713.
41. Carling D. The AMP-activated protein kinase cascade-a unifying system for energy control. Trends Biochem Sci 2004, 29:18-24.
42. Fraser S., Mount P., Hill R., et al. Regulation of the energy sensor AMP-activated protein kinase in the kidney by dietary salt intake and osmolality. Am J Physiol Renal Physiol 2005, 288:F578-F586.
43. Hawley S.A., Davison M., Woods A., et al. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 1996, 271:27879-27887.
44. Merrill G.F., Kurth E.J., Hardie D.G., et al. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle. Am J Physiol 1997, 273:E1107-E1112.
45. Yap F., Craddock L., Yang J. Mechanism of AMPK suppression of LXR-dependent Srebp-1c transcription. Int J Biol Sci 2011, 7:645-650.
46. Lee M.J., Feliers D., Mariappan M.M., et al. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol 2007, 292:F617-F627.
47. Ong A.C., Moorhead J.F. Tubular lipidosis: epiphenomenon or pathogenetic lesion in human renal disease?. Kidney Int 1994, 45:753-762.
48. Jiang H.P., Serrero G. Isolation and characterization of a full-length cDNA coding for an adipose differentiation-related protein. Proc Natl Acad Sci U S A 1992, 89:7856-7860.
49. Londos C., Brasaemle D.L., Schultz C.J., et al. Perilipins, ADRP, and other proteins that associate with intracellular neutral lipid droplets in animal cells. Semin Cell Dev Biol 1999, 10:51-58.
50. Nishida Y., Oda H., Yorioka N. Effect of lipoproteins on mesangial cell proliferation. Kidney Int Suppl 1999, 71:S51-S53.
51. Lee H.S., Kim B.C., Kim Y.S., et al. Involvement of oxidation in LDL-induced collagen gene regulation in mesangial cells. Kidney Int 1996, 50:1582-1590.
52. Garman J.H., Mulroney S., Manigrasso M., et al. Omega-3 fatty acid rich diet prevents diabetic renal disease. Am J Physiol Renal Physiol 2009, 296:F306-F316.
53. Lee M.J., Feliers D., Sataranatarajan K., et al. Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells. Cell Signal 2010, 22:65-70.